8-K/A 1 ivax-8ka.txt AMENDMENT NO. 1 TO FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------------------------- AMENDMENT 1 TO FORM 8-K/A Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 5, 2001 IVAX CORPORATION (Exact Name of Registrant as Specified in its Charter) FLORIDA 1-09623 16-1003559 (State or Other Jurisdiction of Commission File Number) (IRS Employer Incorporation) Identification No.) 4400 BISCAYNE BOULEVARD, MIAMI, FLORIDA 33137 (Address of Principal Executive Offices) (305) 575-6000 (Registrant's Telephone Number, Including Area Code) N/A (Former Name or Former Address, if Changed since Last Report) ----------------------------------- This Amendment 1 to Form 8-K/A amends the Form 8-K filed with the Commission on July 20, 2001 and the Form 8-K/A filed with the Commission on August 1, 2001 relating to the acquisition by IVAX Corporation ("IVAX") of Laboratorio Chile S.A. ("LabChile"). This Amendment 1 to Form 8-K/A is being filed to amend the consent included as Exhibit 23.1 in the Form 8-K/A. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits. The Exhibits to this Amendment 1 to Form 8-K/A are listed on the Exhibit Index and are incorporated herein by reference. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 26, 2001 IVAX CORPORATION By: /s/ Thomas E. Beier --------------------------------- Thomas E. Beier Senior Vice President-Finance Chief Financial Officer 2 Exhibit Index Exhibit Number Description ------ ----------- 23.1 Consent of Arthur Andersen - Langton Clarke